Semaglutide Added to Basal Insulin in Type 2 Diabetes (SUSTAIN 5): A Randomized, Controlled Trial

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1Patient perspectives on once‐weekly medications for diabetes2010 · 128 citations
2. 2Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans.1998 · 1,392 citations
3. 3Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study1995 · 3,104 citations
4. 4Use of Twice-Daily Exenatide in Basal Insulin–Treated Patients With Type 2 Diabetes2011 · 506 citations
5. 5Standards of Medical Care in Diabetes2006 · 8,700 citations